Financhill
Sell
33

SBIO Quote, Financials, Valuation and Earnings

Last price:
$33.63
Seasonality move :
-5.06%
Day range:
$33.22 - $34.27
52-week range:
$31.00 - $42.73
Dividend yield:
3.47%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
4.4K
Avg. volume:
14.8K
1-year change:
11.02%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
SBIO
ALPS Medical Breakthroughs ETF
-- -- -- -- --
BBP
Virtus LifeSci Biotech Products ETF
-- -- -- -- --
PSCH
Invesco S&P SmallCap Health Care ETF
-- -- -- -- --
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
-- -- -- -- --
XBI
SPDR S&P Biotech ETF
-- -- -- -- --
XHE
SPDR S&P Health Care Equipment ETF
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
SBIO
ALPS Medical Breakthroughs ETF
$33.82 -- -- -- $1.17 3.47% --
BBP
Virtus LifeSci Biotech Products ETF
$60.26 -- -- -- $0.00 0% --
PSCH
Invesco S&P SmallCap Health Care ETF
$45.17 -- -- -- $0.07 0.24% --
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
$40.84 -- -- -- $0.03 0.06% --
XBI
SPDR S&P Biotech ETF
$91.28 -- -- -- $0.02 0.16% --
XHE
SPDR S&P Health Care Equipment ETF
$89.31 -- -- -- $0.01 0.04% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
SBIO
ALPS Medical Breakthroughs ETF
-- 1.876 -- --
BBP
Virtus LifeSci Biotech Products ETF
-- 1.316 -- --
PSCH
Invesco S&P SmallCap Health Care ETF
-- 1.996 -- --
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
-- 1.936 -- --
XBI
SPDR S&P Biotech ETF
-- 2.133 -- --
XHE
SPDR S&P Health Care Equipment ETF
-- 1.612 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
SBIO
ALPS Medical Breakthroughs ETF
-- -- -- -- -- --
BBP
Virtus LifeSci Biotech Products ETF
-- -- -- -- -- --
PSCH
Invesco S&P SmallCap Health Care ETF
-- -- -- -- -- --
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
-- -- -- -- -- --
XBI
SPDR S&P Biotech ETF
-- -- -- -- -- --
XHE
SPDR S&P Health Care Equipment ETF
-- -- -- -- -- --

ALPS Medical Breakthroughs ETF vs. Competitors

  • Which has Higher Returns SBIO or BBP?

    Virtus LifeSci Biotech Products ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat Virtus LifeSci Biotech Products ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    SBIO
    ALPS Medical Breakthroughs ETF
    -- -- --
    BBP
    Virtus LifeSci Biotech Products ETF
    -- -- --
  • What do Analysts Say About SBIO or BBP?

    ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Products ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than Virtus LifeSci Biotech Products ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than Virtus LifeSci Biotech Products ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    SBIO
    ALPS Medical Breakthroughs ETF
    0 0 0
    BBP
    Virtus LifeSci Biotech Products ETF
    0 0 0
  • Is SBIO or BBP More Risky?

    ALPS Medical Breakthroughs ETF has a beta of 0.889, which suggesting that the stock is 11.1% less volatile than S&P 500. In comparison Virtus LifeSci Biotech Products ETF has a beta of 0.627, suggesting its less volatile than the S&P 500 by 37.32%.

  • Which is a Better Dividend Stock SBIO or BBP?

    ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 3.47%. Virtus LifeSci Biotech Products ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Products ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SBIO or BBP?

    ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Products ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than Virtus LifeSci Biotech Products ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Products ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for Virtus LifeSci Biotech Products ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SBIO
    ALPS Medical Breakthroughs ETF
    -- -- -- --
    BBP
    Virtus LifeSci Biotech Products ETF
    -- -- -- --
  • Which has Higher Returns SBIO or PSCH?

    Invesco S&P SmallCap Health Care ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat Invesco S&P SmallCap Health Care ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    SBIO
    ALPS Medical Breakthroughs ETF
    -- -- --
    PSCH
    Invesco S&P SmallCap Health Care ETF
    -- -- --
  • What do Analysts Say About SBIO or PSCH?

    ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P SmallCap Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than Invesco S&P SmallCap Health Care ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than Invesco S&P SmallCap Health Care ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    SBIO
    ALPS Medical Breakthroughs ETF
    0 0 0
    PSCH
    Invesco S&P SmallCap Health Care ETF
    0 0 0
  • Is SBIO or PSCH More Risky?

    ALPS Medical Breakthroughs ETF has a beta of 0.889, which suggesting that the stock is 11.1% less volatile than S&P 500. In comparison Invesco S&P SmallCap Health Care ETF has a beta of 0.976, suggesting its less volatile than the S&P 500 by 2.393%.

  • Which is a Better Dividend Stock SBIO or PSCH?

    ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 3.47%. Invesco S&P SmallCap Health Care ETF offers a yield of 0.24% to investors and pays a quarterly dividend of $0.07 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. Invesco S&P SmallCap Health Care ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SBIO or PSCH?

    ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than Invesco S&P SmallCap Health Care ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than Invesco S&P SmallCap Health Care ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while Invesco S&P SmallCap Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for Invesco S&P SmallCap Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SBIO
    ALPS Medical Breakthroughs ETF
    -- -- -- --
    PSCH
    Invesco S&P SmallCap Health Care ETF
    -- -- -- --
  • Which has Higher Returns SBIO or PTH?

    Invesco Dorsey Wright Healthcare Momentum ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    SBIO
    ALPS Medical Breakthroughs ETF
    -- -- --
    PTH
    Invesco Dorsey Wright Healthcare Momentum ETF
    -- -- --
  • What do Analysts Say About SBIO or PTH?

    ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Dorsey Wright Healthcare Momentum ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than Invesco Dorsey Wright Healthcare Momentum ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than Invesco Dorsey Wright Healthcare Momentum ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    SBIO
    ALPS Medical Breakthroughs ETF
    0 0 0
    PTH
    Invesco Dorsey Wright Healthcare Momentum ETF
    0 0 0
  • Is SBIO or PTH More Risky?

    ALPS Medical Breakthroughs ETF has a beta of 0.889, which suggesting that the stock is 11.1% less volatile than S&P 500. In comparison Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.830, suggesting its less volatile than the S&P 500 by 16.97%.

  • Which is a Better Dividend Stock SBIO or PTH?

    ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 3.47%. Invesco Dorsey Wright Healthcare Momentum ETF offers a yield of 0.06% to investors and pays a quarterly dividend of $0.03 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. Invesco Dorsey Wright Healthcare Momentum ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SBIO or PTH?

    ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than Invesco Dorsey Wright Healthcare Momentum ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while Invesco Dorsey Wright Healthcare Momentum ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for Invesco Dorsey Wright Healthcare Momentum ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SBIO
    ALPS Medical Breakthroughs ETF
    -- -- -- --
    PTH
    Invesco Dorsey Wright Healthcare Momentum ETF
    -- -- -- --
  • Which has Higher Returns SBIO or XBI?

    SPDR S&P Biotech ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    SBIO
    ALPS Medical Breakthroughs ETF
    -- -- --
    XBI
    SPDR S&P Biotech ETF
    -- -- --
  • What do Analysts Say About SBIO or XBI?

    ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than SPDR S&P Biotech ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    SBIO
    ALPS Medical Breakthroughs ETF
    0 0 0
    XBI
    SPDR S&P Biotech ETF
    0 0 0
  • Is SBIO or XBI More Risky?

    ALPS Medical Breakthroughs ETF has a beta of 0.889, which suggesting that the stock is 11.1% less volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 0.956, suggesting its less volatile than the S&P 500 by 4.394%.

  • Which is a Better Dividend Stock SBIO or XBI?

    ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 3.47%. SPDR S&P Biotech ETF offers a yield of 0.16% to investors and pays a quarterly dividend of $0.02 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SBIO or XBI?

    ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SBIO
    ALPS Medical Breakthroughs ETF
    -- -- -- --
    XBI
    SPDR S&P Biotech ETF
    -- -- -- --
  • Which has Higher Returns SBIO or XHE?

    SPDR S&P Health Care Equipment ETF has a net margin of -- compared to ALPS Medical Breakthroughs ETF's net margin of --. ALPS Medical Breakthroughs ETF's return on equity of -- beat SPDR S&P Health Care Equipment ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    SBIO
    ALPS Medical Breakthroughs ETF
    -- -- --
    XHE
    SPDR S&P Health Care Equipment ETF
    -- -- --
  • What do Analysts Say About SBIO or XHE?

    ALPS Medical Breakthroughs ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Health Care Equipment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that ALPS Medical Breakthroughs ETF has higher upside potential than SPDR S&P Health Care Equipment ETF, analysts believe ALPS Medical Breakthroughs ETF is more attractive than SPDR S&P Health Care Equipment ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    SBIO
    ALPS Medical Breakthroughs ETF
    0 0 0
    XHE
    SPDR S&P Health Care Equipment ETF
    0 0 0
  • Is SBIO or XHE More Risky?

    ALPS Medical Breakthroughs ETF has a beta of 0.889, which suggesting that the stock is 11.1% less volatile than S&P 500. In comparison SPDR S&P Health Care Equipment ETF has a beta of 1.012, suggesting its more volatile than the S&P 500 by 1.225%.

  • Which is a Better Dividend Stock SBIO or XHE?

    ALPS Medical Breakthroughs ETF has a quarterly dividend of $1.17 per share corresponding to a yield of 3.47%. SPDR S&P Health Care Equipment ETF offers a yield of 0.04% to investors and pays a quarterly dividend of $0.01 per share. ALPS Medical Breakthroughs ETF pays -- of its earnings as a dividend. SPDR S&P Health Care Equipment ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SBIO or XHE?

    ALPS Medical Breakthroughs ETF quarterly revenues are --, which are smaller than SPDR S&P Health Care Equipment ETF quarterly revenues of --. ALPS Medical Breakthroughs ETF's net income of -- is lower than SPDR S&P Health Care Equipment ETF's net income of --. Notably, ALPS Medical Breakthroughs ETF's price-to-earnings ratio is -- while SPDR S&P Health Care Equipment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ALPS Medical Breakthroughs ETF is -- versus -- for SPDR S&P Health Care Equipment ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SBIO
    ALPS Medical Breakthroughs ETF
    -- -- -- --
    XHE
    SPDR S&P Health Care Equipment ETF
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 4.28% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 9.4% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.15% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock